Clinical usefulness of des-?-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma
Authors:
- 1 December 1991
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 36 (12) , 1787-1792
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Plasma Des–γ–Carboxyprothrombin in the Early Stage of Hepatocellular CarcinomaHepatology, 1990
- A comparison between des‐γ‐carboxy prothrombin and α‐fetoprotein as markers of hepatocellular carcinoma in southern African BlacksJournal of Gastroenterology and Hepatology, 1989
- α-fetoprotein monitoring in chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinomaHepatology, 1989
- Application of Des-γ-Carboxy Prothrombin as a Complementary Tumor Marker with Alpha-Fetoprotein in the Diagnosis of Hepatocellular CarcinomaScandinavian Journal of Gastroenterology, 1989
- PLASMA ABNORMAL PROTHROMBIN LEVELS IN PATIENTS WITH SMALL HEPATOCELLULAR-CARCINOMA1988
- Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinomaJournal of Hepatology, 1987
- Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.1986
- Detection of Vitamin K Deficiency by Use of an Enzyme-Linked Immunosorbent Assay for Circulating Abnormal ProthrombinPediatric Research, 1985
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966